# Andrei Georgescu

> Andrei Georgescu is the co-founder and CEO of Vivodyne, a biotech company that grows human tissues in the lab and runs drugs through them with robots and AI before any human ever swallows a pill. A University of Pennsylvania bioengineering PhD who once sent lab-grown tissue to space with NASA, he started Vivodyne in 2020 because roughly 19 of every 20 drugs that work in animals fail in people. His pitch is blunt: test human medicine on human tissue, not on mice. In May 2025 Vivodyne raised a $40 million Series A led by Khosla Ventures to scale a 23,000-square-foot fully robotic lab in South San Francisco.

- **Role:** Co-Founder & CEO at Vivodyne
- **Organizations:** Vivodyne, University of Pennsylvania, Cornell University
- **Nationality:** American
- **Education:** Ph.D. in Bioengineering (Dr. Dan Huh's organ-chip lab), University of Pennsylvania, B.S. and M.Eng. in Bioengineering, Cornell University
- **Known for:** Co-founded and leads Vivodyne, a Penn spinout valued on the strength of lab-grown human tissue testing, Raised roughly $80M total, including a $40M Series A (2025) and $38M seed, both led by Khosla Ventures, Built a platform that grows 20+ human organ types and runs 10,000+ independent tissue experiments per robotic run

## Career timeline

- **pre-2020** — Trained in bioengineering at Cornell, then completed a PhD in Dan Huh's organ-on-a-chip lab at the University of Pennsylvania. Sent lab-grown tissues to space with NASA and developed DNA synthesis chips.
- **2020** — Co-founded Vivodyne with Penn bioengineering professor Dan Huh, motivated by the loss of translation between animal studies and human trials.
- **2021** — Completed doctorate at the University of Pennsylvania.
- **2023** — Vivodyne announced a $38 million seed financing led by Khosla Ventures; company publicly launched its lab-grown human tissue drug-testing platform.
- **2025** — Vivodyne raised a $40 million Series A led by Khosla Ventures and opened a 23,000-square-foot fully robotic lab at Genesis Marina in South San Francisco.

## Achievements

- Co-founded and leads Vivodyne, a Penn spinout valued on the strength of lab-grown human tissue testing
- Raised roughly $80M total, including a $40M Series A (2025) and $38M seed, both led by Khosla Ventures
- Built a platform that grows 20+ human organ types and runs 10,000+ independent tissue experiments per robotic run
- Sent lab-grown tissues to space with NASA
- Developed DNA synthesis chips that became industry standards
- Opened a 23,000-square-foot fully robotic laboratory in South San Francisco

## Latest updates

- **2025-05** — Vivodyne raised a $40 million Series A led by Khosla Ventures and announced a 23,000-square-foot fully robotic lab at Genesis Marina in South San Francisco.

## Links

- Website: https://vivodyne.com
- LinkedIn: http://www.linkedin.com/in/andrei-georgescu-phd
- Twitter/X: https://twitter.com/vivodyne

---

Profile page: https://yespress.io/andrei-georgescu
Published by YesPress — https://yespress.io
Last updated: 2026-06-14